Trial of KN026 in Patients With HER2-positive Advanced Malignant Breast Cancer and Gastric Cancer
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Gastric Cancer
Interventions: DRUG: KN026
Sponsor: Jiangsu Alphamab Biopharmaceuticals Co., Ltd